Clinical Trials Browser

Phase 2 × Breast Neoplasms × dactolisib × Clear all

NCT01288092 2012-06-07

BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms